As filed with Securities and Exchange Commission on June 12, 2026
Registration No. 333-
Bermuda | 4412 | N/A | ||||
(State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) | ||||
† | The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012. |

• | the designation, aggregate principal amount and authorized denominations; |
• | the issue price, expressed as a percent of the aggregate principal amount; |
• | the maturity date; |
• | the interest rate per annum, if any; |
• | if the offered debt securities provide for interest payments, the date from which interest will accrue, the dates on which interest will be payable, the date on which payment of interest will commence, and the regular record dates for interest payment dates; |
• | whether the debt securities will be our secured or unsecured obligations; |
• | any period or periods during which, and the price or prices at which, we will have the option to or be required to redeem or repurchase the debt securities of the series and the other material terms and provisions applicable to such redemption or repurchase; |
• | any optional or mandatory sinking fund provisions; |
• | any conversion or exchangeability provisions; |
• | if other than denominations of $1,000 and any integral multiple thereof, the denominations in which debt securities of the series will be issuable; |
• | if other than the full principal amount, the portion of the principal amount of the debt securities of the series which will be payable upon acceleration or provable in bankruptcy; |
• | any events of default not set forth in this prospectus; |
• | any subordination provisions that will apply to the debt securities; |
• | the currency or currencies, including composite currencies, in which principal, premium, if any, and interest will be payable, if other than the currency of the United States; |
• | if principal, premium or interest is payable, at our election or at the election of any holder, in a currency other than that in which the debt securities of the series are stated to be payable, the period or periods within which, and the terms and conditions upon which, the election may be made; |
• | whether interest will be payable in cash or additional securities at our or the holder’s option and the terms and conditions upon which the election may be made; |
• | if denominated in a currency or currencies other than the currency of the United States, the equivalent price in the currency of the United States for purposes of determining the voting rights of holders of those debt securities under the applicable Indenture; |
• | if the amount of payments of principal, premium, or interest may be determined with reference to an index, formula or other method based on a coin or currency other than that in which the debt securities of the series are stated to be payable, the manner in which the amounts will be determined; |
• | any covenants or other material terms relating to the debt securities, which may not be inconsistent with each Indenture; |
• | whether the debt securities will be issued in the form of global securities or certificates in registered or bearer form; |
• | any listing on any securities exchange or quotation system; |
• | additional provisions, if any, related to defeasance and discharge of the debt securities; and |
• | any other special features of the debt securities. |
• | our ability to incur either secured or unsecured debt, or both; |
• | our ability to make certain payments, dividends, redemptions, or repurchases; |
• | our ability to create dividend and other payment restrictions affecting our subsidiaries; |
• | our ability to make investments; |
• | mergers and consolidations by us; |
• | sales of assets by us; |
• | our ability to enter into transactions with affiliates; and |
• | our ability to incur liens. |
(i) | change the amount of debt securities whose holders must consent to an amendment, supplement or waiver; |
(ii) | reduce the rate of or changes the interest payment time on any debt security or alter its redemption provisions (other than any alteration to any such section which would not materially adversely affect the legal rights of any debt holder under the applicable Indenture) or the price at which we are required to offer to purchase the debt securities; |
(iii) | reduce the principal or changes the maturity of any debt security or reduces the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation; |
(iv) | waive a default or event of default in the payment of the principal of or interest, if any, on any debt security (except a rescission of acceleration of the debt securities of any series by the holders of at least a majority in principal amount of the outstanding debt securities of that series and a waiver of the payment default that resulted from such acceleration); |
(v) | makes the principal of or interest, if any, on any debt security payable in any currency other than that stated in the debt security; |
(vi) | make any change with respect to debt holders’ rights to receive principal and interest, the terms pursuant to which defaults can be waived, certain modifications affecting shareholders or certain currency-related issues; or |
(vii) | waive a redemption payment with respect to any debt security or changes any of the provisions with respect to the redemption of any debt securities. |
• | default in any payment of interest when due which continues for 30 days; |
• | default in any payment of principal or premium when due; |
• | default in the deposit of any sinking fund payment when due; |
• | default in the performance of any covenant in the debt securities or the Indentures which continues for 60 days after we receive notice of the default; |
• | default under a bond, debenture, note, or other evidence of indebtedness for borrowed money by us or our subsidiaries (to the extent we are directly responsible or liable therefor) having a principal amount in |
• | events of bankruptcy, insolvency, or reorganization. |
• | the title of such warrants; |
• | the aggregate number of such warrants; |
• | the price(s) at which such warrants will be issued; |
• | the currency or currencies, in which the price of such warrants will be payable; |
• | the securities or other rights, including rights to receive payment in cash or securities based on the value, rate or price of one or more specified commodities, currencies, securities, or indices, or any combination of the foregoing, purchasable upon exercise of such warrants; |
• | the price at which and the currency or currencies, in which the securities or other rights purchasable upon exercise of such warrants may be purchased; |
• | the date on which the right to exercise such warrants shall commence and the date on which such right shall expire; |
• | if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time; |
• | if applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued with each such security; |
• | if applicable, the date on and after which such warrants and the related securities will be separately transferable; |
• | information with respect to book-entry procedures, if any; |
• | if applicable, a discussion of any material U.S. federal income tax considerations; and |
• | any other terms of such warrants, including terms, procedures, and limitations relating to the exchange and exercise of such warrants. |
• | debt or equity securities issued by us or offered or sold by third parties, a basket of such securities, an index or indices of such securities, or any combination of the aforementioned, as specified in an applicable prospectus supplement; |
• | currencies; or |
• | commodities. |
• | the exercise price for the rights; |
• | the number of rights issued to each securityholder; |
• | the extent to which the rights are transferable; |
• | any other terms of the rights, including terms, procedures, and limitations relating to the exchange and exercise of the rights; |
• | the date on which the right to exercise the rights (“rights” or “subscription rights”) will commence and the date on which the rights will expire; |
• | the amount of rights outstanding; |
• | the extent to which the rights include an over-subscription privilege with respect to unsubscribed Securities; and |
• | the material terms of any standby underwriting arrangement entered into by us in connection with the rights offering. |
• | the terms of the units and of the rights, purchase contracts, warrants, debt securities, preferred shares, and common shares comprising the units, including whether and under what circumstances the securities comprising the units may be traded separately; |
• | a description of the terms of any unit agreement governing the units; and |
• | a description of the provisions for the payment, settlement, transfer, or exchange of the units. |
• | purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus supplement and the accompanying prospectus; |
• | ordinary brokerage transactions and transactions in which the broker solicits purchasers; |
• | an exchange distribution in accordance with the rules of the NYSE or other exchange or trading system on which the Shares are admitted for trading privileges; |
• | sales “at the market” to or through a market maker or into an existing trading market (on an exchange or otherwise), for the Securities; |
• | sales in other ways not involving market makers or established trading markets; |
• | through put or call transactions relating to the Securities; |
• | block trades in which the broker-dealer will attempt to sell the Securities as agent but may position and resell a portion of the block as principal to facilitate the transaction; |
• | in privately negotiated transactions; and |
• | trading plans pursuant to Rule 10b5-1 under the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any prospectus supplement hereto that provide for periodic sales of securities on the basis of parameters described in such trading plans. |
• | any underwriters, dealers or agents; |
• | their compensation; |
• | the net proceeds to us; |
• | the purchase price of the Securities; |
• | the public offering price of the Securities; |
• | any discounts or concessions allowed or reallowed; and |
• | confirm any exchange on which the Securities will be listed, if any. |
• | commercial and savings banks; |
• | insurance companies; |
• | pension funds; |
• | investment companies; |
• | educational and charitable institutions; and |
• | other similar institutions as we or the selling securityholder may approve. |
• | the validity of the arrangements; or |
• | the performance by us or the institutional investor. |
• | our 2025 Annual Report filed on Form 20-F; |
• | our Report on Form 6-K dated May 21, 2026 (2026 AGM Results Notification) |
• |
• | our Report on Form 6-K dated May 27, 2026; and |
• | with respect to each offering of Securities under this prospectus, all our future reports on Form 20-F, and any report on Form 6-K that so indicates it is being incorporated by reference, in each case, that we file with the SEC or furnish to the SEC on or after the date on which the registration statement is first filed with the SEC and until the termination or completion of that offering under this prospectus. |
Item 8. | Indemnification of Directors and Officers |
Item 9. | Exhibits and Financial Statement Schedules |
(a) | The following exhibits are filed as part of this registration statement: |
Exhibit No. | Document | ||
1.1** | Form of Underwriting Agreement | ||
3.1*** | Certificate of Incorporation (incorporated by reference from Exhibit 3.1 to the Registration Statement filed on Form F-1, dated March 7, 2023) | ||
3.2*** | Memorandum of Association (incorporated by reference from Exhibit 3.2 to the Registration Statement filed on Form F-1, dated March 7, 2023) | ||
3.3*** | Amended and Restated Bye-laws (incorporated by reference from Exhibit 3.3 to the Registration Statement filed on Form F-1, dated March 7, 2023) | ||
4.1** | Form of Warrant | ||
4.2** | Form of Unit Agreement | ||
4.3* | Form of Indenture | ||
5.1* | Opinion of Conyers Dill & Pearman Limited, Bermuda counsel to the Registrant, as to the validity of Shares. | ||
5.2* | Opinion of Skadden, Arps, Slate, Meagher and Flom (UK) LLP | ||
23.1* | Consent of PricewaterhouseCoopers AS | ||
23.2* | Consent of Conyers Dill & Pearman Limited (included in Exhibit 5.1). | ||
24.1* | Power of Attorney (included on the signature page of the registration statement). | ||
107.1* | Filing Fee Table | ||
* | Filed herewith. |
** | To be filed, if necessary, by amendment or as an exhibit to a document to be incorporated by reference into this registration statement. |
*** | Previously filed. |
Item 10. | Undertakings |
(a) | The undersigned hereby undertakes: |
(1) | to file, during any period in which offers or sales are being made of Securities registered hereby, a post-effective amendment to this registration statement: |
(i) | to include any prospectus required by Section 10(a)(3) of the Securities Act; |
(ii) | to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of Securities offered (if the total dollar value of Securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; |
(iii) | to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; |
(2) | that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the Securities offered herein, and the offering of such Securities at that time shall be deemed to be the initial bona fide offering thereof. |
(3) | to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(4) | to file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Securities Act need not be furnished, provided that the Registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, with respect to registration statements on Form F-3, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Securities Act or Item 8.A of Form 20-F if such financial statements and information are contained in periodic reports filed with or furnished to the SEC by the Registrant pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference in this Form F-3. |
(5) | that, for the purpose of determining liability under the Securities Act to any purchaser: |
(i) | each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and |
(ii) | each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of Securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the Securities in the registration statement to which the prospectus relates, and the offering of such Securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in the registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. |
(6) | that, for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of the securities the undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the Securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
(i) | any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424; |
(ii) | any free writing prospectus (“FWP”) relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant; |
(iii) | the portion of any other FWP relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and |
(iv) | any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser. |
(b) | The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual reports pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the Securities offered therein, and the offering of such Securities at that time shall be deemed to be the initial bona fide offering thereof. |
(c) | Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. |
(d) | The undersigned Registrant hereby undertakes to file an application for the purpose of determining eligibility of the trustee to act under subsection (a) of section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the SEC under section 305(b)(2) of the Trust Indenture Act, to the extent an indenture is required. |
Exhibit Number | Description of Document | ||
1.1** | Form of the Underwriting Agreement | ||
Certificate of Incorporation (incorporated by reference from Exhibit 3.1 to the Registration Statement filed on Form F-1, dated March 7, 2023) | |||
Memorandum of Association (incorporated by reference from Exhibit 3.2 to the Registration Statement filed on Form F-1, dated March 7, 2023) | |||
Amended and Restated Bye-laws (incorporated by reference from Exhibit 3.3 to the Registration Statement filed on Form F-1, dated March 7, 2023) | |||
4.1** | Form of Warrant | ||
4.2** | Form of Unit Agreement | ||
Form of Indenture | |||
Opinion of Conyers Dill & Pearman Limited | |||
Opinion of Skadden, Arps, Slate, Meagher & Flom (UK) LLP | |||
23.1** | Consent of PricewaterhouseCoopers LLP, an independent registered public accounting firm | ||
Consent of Conyers Dill & Pearman Limited (included in Exhibit 5.1) | |||
Consent of Skadden, Arps, Slate, Meagher & Flom (UK) LLP (Included in Exhibit 5.2) | |||
Powers of Attorney (included on signature page) | |||
25.1** | Statement of eligibility of Trustee on Form T-1 with respect to the Company under any indenture | ||
Registration Fee Table | |||
* | Filed herewith. |
** | To be filed, if necessary, by amendment or as an exhibit to a document to be incorporated by reference into this registration statement. |
*** | Previously filed |
Himalaya Shipping Ltd. | |||||||||
By: | /s/ Lars-Christian Svenson | ||||||||
Name: | Lars-Christian Svenson | ||||||||
Title: | Chief Executive Officer | ||||||||
By: | /s/ Vidar Hasund | ||||||||
Name: | Vidar Hasund | ||||||||
Title: | Chief Financial Officer | ||||||||
Signature | Title | Date | ||||
/s/ Lars-Christian Svensen | Chief Executive Officer | June 12, 2026 | ||||
Lars-Christian Svensen | ||||||
/s/ Vidar Hasund | Chief Financial Officer | June 12, 2026 | ||||
Vidar Hasund | ||||||
/s/ Bjorn Isaksen | Director | June 12, 2026 | ||||
Bjorn Isaksen | ||||||
/s/ Jehan Mawjee | Director | June 12, 2026 | ||||
Jehan Mawjee | ||||||
/s/ Alexandra Kate Blankenship | Director | June 12, 2026 | ||||
Alexandra Kate Blankenship | ||||||
/s/ Carl Steen | Director | June 12, 2026 | ||||
Carl Steen | ||||||
/s/ Mi Hong Yoon | Director | June 12, 2026 | ||||
Mi Hong Yoon | ||||||
Authorized U.S. Representative – Puglisi & Associates. | ||||||||||||
By: | /s/ Donald J. Puglisi | |||||||||||
Name: | Donald J. Puglisi | |||||||||||
Title: | Managing Director | |||||||||||